NEW YORK, Sept. 02, 2024 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., September 2, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of CAE Inc. (NYSE: CAE) between February 11, 2022 and May 21, 2024, both dates inclusive (the “Class Period”), of the important September 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased CAE stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ar ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2024. SO WHAT: If you purchased Endava securities during the Class ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DXC Technology Company (NYSE: DXC) between May 26, 2021 and May 16, 2024, both dates inclusive (the “Class Period”), of the important October 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased DXC common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

文章核心观点 - 公司Outset Medical被指在2022年8月1日至2024年8月7日期间做出了虚假或误导性陈述,未能披露以下信息[4]: 1) Tablo产品被用于连续性肾脏替代治疗,这并非美国FDA批准的适应症之一 2) 因此Outset Medical很可能需要提交额外的510(k)申请用于Tablo产品 3) 存在Outset Medical可能暂停Tablo产品销售直至FDA批准新适应症的重大风险 4) Outset Medical缺乏执行Tablo销售增长的销售团队和流程 5) 上述因素将对公司的收入增长产生不利影响 6) 因此公司关于业务、运营和前景的积极声明存在重大误导性和缺乏合理依据 根据目录分别总结 1. 文章概述 - 罗森律师事务所代表Outset Medical公司证券购买者提起集体诉讼[1][2] - 诉讼时间范围为2022年8月1日至2024年8月7日[1] - 如果您在此期间购买了Outset Medical证券,您可能有权获得赔偿[1][2] 2. 诉讼详情 - 公司涉嫌在上述期间做出虚假或误导性陈述,未能披露以下信息[4]: 1) Tablo产品被用于连续性肾脏替代治疗,这并非FDA批准的适应症 2) 公司很可能需要提交额外的510(k)申请用于Tablo产品 3) 存在公司可能暂停Tablo产品销售的重大风险 4) 公司缺乏执行Tablo销售增长的销售团队和流程 5) 上述因素将对公司的收入增长产生不利影响 6) 因此公司关于业务、运营和前景的积极声明存在重大误导性和缺乏合理依据 3. 加入诉讼 - 如果您在上述期间购买了Outset Medical证券,您可以通过以下方式加入集体诉讼[2][5]: 1) 访问https://rosenlegal.com/submit-form/?case_id=17760 2) 致电Phillip Kim律师,电话866-767-3653 3) 发送电子邮件至case@rosenlegal.com

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024 in the securities class action first filed by the Firm. ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) between November 29, 2023 and July 29, 2024, both dates inclusive (the “Class Period”), of the important September 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased CrowdStrike Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thro ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased Ardelyx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT T ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of lululemon athletica inc. (NASDAQ: LULU) between December 7, 2023 and July 24, 2024, both dates inclusive (the “Class Period”), of the important October 7, 2024 lead plaintiff deadline. SO WHAT: If you purchased lululemon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

NEW YORK, Aug. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of XPEL, Inc. (NASDAQ: XPEL) between November 8, 2023 and May 2, 2024, both dates inclusive (the “Class Period”), of the important October 7, 2024 lead plaintiff deadline. SO WHAT: If you purchased XPEL securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEX ...

NEW YORK, Aug. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ford Motor Company (NYSE: F) between April 27, 2022 and July 24, 2024, both dates inclusive (the “Class Period”), of the important October 7, 2024 lead plaintiff deadline. SO WHAT: If you purchased Ford securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO ...